Journal Guide

MHR publishes articles on the molecular aspects of human reproductive physiology and pathology, endocrinology, andrology,gonadal function, gametogenesis, fertilization, embryo development, implantation, pregnancy and contraception. Reproductive genetics is also an important part of MHR. Studies on animal models are welcome as long as a clear relevance to human reproduction can be shown. Published papers include peer-reviewed original research reports, short review articles and commentaries. MHR is published on behalf of the European Society of Human Reproduction and Embryology.

Molecular Imaging and Biology presents original research contributions on the utilization of molecular imaging in problems of relevance in biology and medicine. The primary objective of the journal is to provide a forum for the discovery of molecular mechanisms of health and disease through the use of imaging techniques. Among the topics covered are molecular imaging investigations of macromolecular targets involved in significant biological processes; design and evaluation of molecular probes used to investigate macromolecular targets and their functions; and study of in vivo animal models of disease for the development of new molecular diagnostics and therapeutics.The overall goal is to translate basic science discoveries into molecular imaging of disease in patients, both to investigate the biological nature of disease in actual patients and to establish new molecular imaging diagnostic procedures.Molecular Imaging and Biology is the official journal of the World Molecular Imaging Society and the Europea

Molecular Immunology is primarily devoted to publications concerned with immunological knowledge at the molecular, cellular and functional levels of innate and acquired immunity, including but not limited to:• molecular mechanisms of innate and adaptive immunity phenomena• molecular aspects of immune regulation• cell signalling and activation; cellular receptors and soluble mediators• immunogenomics, immunoproteomics and immunoglycomics• molecular (immuno) therapeutics• immunochemistry• impact of molecular changes at the tissue levelBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Aims and Scope Download Flyer Molecular Informaticsis a peer-reviewed. international forum for publication of high-quality. interdisciplinary research on all molecular aspects of bio/cheminformatics and computer-assisted molecular design.Molecular InformaticssucceededQSAR and Combinatorial Science(2009 Journal Impact Factor: 3.027) in 2010. Molecular Informaticspresents methodological innovations that will lead to a deeper understanding of ligand-receptor interactions. macromolecular complexes. molecular networks. design concepts and processes that demonstrate how ideas and design concepts lead to molecules with a desired structure or function. preferably including experimental validation. The journal"s scope includes but is not limited to the fields of drug discovery and chemical biology. protein and nucleic acid engineering and design. the design of nanomolecular structures. strategies for modeling of macromolecular assemblies. molecular networks and systems. pharmaco- and chemogenomics. computer-assisted screening strategies. as well as novel technologies for the de novo design of biologically active molecules. As a unique featureMolecular Informaticspublishes so-called 'Methods Corner' review-type articles which feature important technological concepts and advances within the scope of the journal. ISSN: 1868-1743 (print). 1868-1751 (online). Volume 30. 12 Issues in 2011. Masthead Masthead(PDF) –[Show history][Hide history] How to cite:To make sure that references to this journal are correctly recorded and resolved (for example in CrossRef or ISI Web of Science). please use the following abbreviated title in any citations: 'Mol. Inf.' (punctuation may vary according to the style of the citing journal).

Molecular Medicine is the international, peer-reviewed, biomedical journal published by the Feinstein Institute for Medical Research (New York). Molecular Medicine strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. Manuscripts submitted to the journal should maintain this focus and describe the implications for human disease, at a level approachable by the broad readership of Molecular Medicine. The 2011 Journal Citation Report (JCR), showing impact factors calculated from citations of articles published in 2010 and 2009, lists Molecular Medicine with an impact factor of 3.757. JCR category rankings are as follows: Medicine, Research & Experimental 24/111, Cell Biology 72/180, Biochemistry & Molecular Biology 91/289. Molecular Medicine publishes work in the format of original research articles, review articles, editorials, commentaries and letters to the editor covering emerging concepts in the interdisciplinary field of molecular medicine.Molecular Medicine places high priority on rapid publication. All content is published free online, ahead of print, within an average of 8 days after acceptance on our Web site www.molmed.org. Following acceptance, papers are posted rapidly to PubMed, with an e-publication ahead of print citation. Molecular Medicine is an open access journal and does not embargo content.

* Biological Abstracts® (Thomson ISI) * BIOSIS Previews® (Thomson ISI) * Chemical Abstracts Service (CAS) * EMBASE (Elsevier) * Google Scholar * Index Copernicus (IC) * Index Medicus/MEDLINE/PubMed (NLM) * Journal Citation Reports (JCR) Science Edition (Thomson ISI) * Science Citation Index Expanded® (Thomson ISI) * Scopus (Elsevier).

Recent advances in molecular biology, cell biology, biochemistry and biophysics have led to a spectacular increase in the understanding of biological membranes at the molecular level. Molecular Membrane Biology provides a forum for membrane researchers from diverse disciplines who have a primary interest in the study of biomembranes at the molecular level. Molecular Membrane Biology publishes high quality original papers and reviews that serve to advance knowledge and research in all molecular aspects of membrane structure and function including:Receptors and signallingTransporters, pores and channelsSynthesis and structure of membrane proteinsTranslocation and targetingLipid organisation and asymmetryModel membranesMembrane fusion, endocytosis, exocytosis and recyclingCytoskeletal and extracellular interactionsCell adhesion and intercellular interactionsMolecular dynamics and molecular modelling of membranes Read More: http://informahealthcare.com/page/mbc/Description.

Molecular Metabolism is committed to serving as a platform reporting breakthroughs from all stages of the discovery and development of novel and improved personalized medicines for obesity, diabetes and associated diseases. The journal aims to publish hypothesis driven research of leading scientists paving the way to a better understanding of metabolic physiology, thereby enabling progress toward prevention and ultimately a cure of the metabolic syndrome. Molecular Metabolism reports interdisciplinary science with the potential for transformative impact on today's metabolism research, focusing on translation of major basic research discoveries toward the personalized medicines needed to prevent and cure diabesity and associated diseases tomorrow.

Molecular Microbiology, the leading primary journal in microbial sciences, publishes research articles reporting the results of molecular studies of eukaryotic microorganisms and of prokaryotes (bacteria and archaea) and their viruses. Studies that include genetic, biochemical, biophysical, bioinformatic and structural analyses leading to a deeper understanding of the molecular principles underlying basic physiological processes or mechanisms are considered as potentially suitable for publication in the Journal. Topics that are considered appropriate include gene expression and regulation, pathogenicity and virulence, physiology and metabolism, synthesis of macromolecules (proteins, nucleic acids, lipids, polysaccharides, etc), cell biology and subcellular organization, membrane biogenesis and function, traffic and transport, cell-cell communication and signalling pathways, evolution and gene transfer. Molecular Microbiology also regularly commissions MicroReviews covering these areas of research, as well as occasional topical MicroCommentaries and other special interest articles. MicroMeeting Reports will also appear in forthcoming issues. These are personal accounts of the most recent and exciting developments in a particular aspect of microbial molecular biology, as presented at a recent symposium, workshop, colloquium or congress, written by one or more of the participants. Articles focused on host responses (cellular or immunological) to pathogens and on molecular aspects of microbial ecology should be directed to our sister journals Cellular Microbiology and Environmental Microbiology, respectively. Average submission to first decision is 23 days!.

Molecular Neurodegeneration is ready to receive manuscripts on all aspects of neurodegeneration research at the molecular and cellular levels.

Aims & Scope Molecular Nutrition & Food Research is a primary research journal devoted to health, safety and all aspects of molecular nutrition such as nutritional biochemistry, nutrigenomics and metabolomics aiming to link the information arising from related disciplines:

Molecular Omics publishes high-quality research from across the -omics sciences that provide significant new insight into important chemical or biological problems. Topics covered by Molecular Omics include, but are not limited to, proteomics, genomics, transcriptomics, lipidomics, glycomics, metabolomics, microbiomics, sequencing technologies and bioinformatic research. Molecular Omics articles report research that significantly increases understanding or demonstrates clear functional benefits, supported by experimental validation or a novel data analytic approach. Topics include, but are not limited to: -omics studies to gain mechanistic insight into biological processes; -omics studies for clinical applications with experimental validation, such as finding biomarkers for diagnostics or potential new drug targets; -omics studies looking at the sub-cellular make-up of cells – for example, the subcellular localisation of certain proteins or post-translational modifications or new imaging techniques; studies presenting new methods and tools to support omics studies, including new spectroscopic/chromatographic techniques, chip-based/array technologies and new classification/data analysis techniques.

Molecular Pain is ready to receive manuscripts on all aspects of pain research at the cellular, subcellular and molecular levels. Molecular Pain is sponsored by the University of Cincinnati College of Medicine.

Molecular Pharmaceutics publishes original theoretical and experimental research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. Modalities of interest include small molecules, imaging agents, proteins, peptides, vaccines, cell and gene-based therapies, and their characterization, formulation, and delivery. Scientific areas within the scope of the journal include:

• Modelling and simulation to aid mechanistic insights into drug delivery
• Molecular understanding of formulations
• Formulation performance under physiological conditions
• Materials science as it relates to drug, excipients, and drug delivery system efficacy.
• Emerging techniques and technologies for drug delivery including theranostics, precision medicine, and artificial intelligence

Submission of a manuscript to Molecular Pharmaceutics implies that the same work has not been previously published, including as part of a public electronic database (preprint servers like bioRxiv and ChemRxiv are permissible), and is not under consideration for publication elsewhere. In addition, there must be no legal restrictions to publication, e.g., patent activities, at the time of submission.

Monthly issues present original applications of biochemistry, biophysics, genetics, and molecular biology juxtaposed with innovative pharmacologic research to elucidate basic problems in pharmacology and toxicology, including areas such as molecular mechanisms involved in drug receptor-effective coupling, xenobiotic metabolism, and antibiotic and anticancer drug action.Molecular Pharmacology is archived in CLOCKSS.

Molecular Phylogenetics and Evolution is dedicated to bringing Darwin's dream within grasp - to "have fairly true genealogical trees of each great kingdom of Nature." The journal provides a forum for molecular studies that advance our understanding of phylogeny and evolution, further the development of phylogenetically more accurate taxonomic classifications, and ultimately bring a unified classification for all the ramifying lines of life. Phylogeographic studies will be considered for publication if they offer EXCEPTIONAL theoretical or empirical advances.The journal encourages articles that are multidisciplinary, especially in areas, such as bioinformatics, computational biology, molecular biology, and organismic biology, that are of interest to the community of systematic and evolutionary biologists. In addition, presentations of new findings on or insights into evolutionary processes and mechanisms as expressed at the molecular level are welcome, as are those that deal with the methodology of reconstructing evolutionary history from molecular data (such as descriptions of new or more powerful computer algorithms for constructing phylogenetic trees from orthologous nucleotide or aminoacid sequences). A deeper understanding of the mechanisms and processes of molecular evolution should lead to more accurate models of molecular evolution, which in turn should facilitate the development of better algorithms for reconstructing evolutionary history from sequence data.Papers based on few taxa, single molecular markers, or that use codon-based methods to test for positive Darwinian selection, but in the absence of experimental evidence that allegedly selected amino acid changes cause an adaptive phenotypic effect, will not be accepted.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Molecular Physics is a well-established international journal publishing original high quality papers in chemical physics and physical chemistry. The journal covers all experimental and theoretical aspects of molecular science, from electronic structure, molecular dynamics, spectroscopy and reaction kinetics to condensed matter, surface science, and statistical mechanics of simple and complex fluids. Contributions include full papers, preliminary communications, research notes and invited topical review articles.All published research articles in Molecular Physics have undergone rigorous peer review, based on initial editor screening and anonymized refereeing by expert referees.* Click here to gain free access to highlight articles selected by the Editors in the following fields: Chemical Dynamics, Photophysics and Spectroscopy Statistical Mechanics of Liquids, Soft Matter and Complex Systems Quantum Chemistry and Electronic Structure Theory * Molecular Physics Longuet-Higgins Young Author's PrizeTo read the winning papers and winner's profile for free, as well as for details on how to enter next year's $1000 prize, go to the prize website. DisclaimerTaylor & Francis makes every effort to ensure the accuracy of all the information (the "Content") contained in its publications. However, Taylor & Francis and its agents and licensors make no representations or warranties whatsoever as to the accuracy, completeness or suitability for any purpose of the Content and disclaim all such representations and warranties whether express or implied to the maximum extent permitted by law. Any views expressed in this publication are the views of the authors and are not the views of Taylor & Francis.

Molecular Plant is a recently founded international journal that publishes significant findings in plant biology, focusing broadly on cellular biology, physiology, molecular biology, genetics, development, and evolution.The journal features a strong international editorial board and is set to become a top-tier journal in the field, using rigorous review to limit the journal to papers that provide novel insights of high impact. The editors particularly encourage submissions of original research that is highly novel but not necessarily fully-developed. Contributions may comprise Research Articles, Review Articles, Methods, Editorials, and Commentaries.To set the standard for its future, most of the papers published in Molecular Plant's first two years were commissioned by editorial members and published in Special Issues on particularly exciting and important topics in current plant biology. Now that the journal's standard has been established, Molecular Plant now receives large numbers of high-quality unsolicited submissions, which have been published under the heading 'Topics of General Interest' since May 2009.The journal is steadily increasing the proportion of regular submissions published. Plant biology authors are strongly encouraged to submit their best work to the journal. Every effort is made to ensure papers are fully reviewed within four weeks and that all accepted papers are published online in their final format within four weeks of arrival of the finished manuscript at the publisher.Assessment by the China Association for Science and Technology of ‘top journals in China’ (in 2010) rated Molecular Plant one of seven A-class journals. .

MPMI has instituted a feature called First Look. Within a few days of acceptance, papers by authors who choose to participate will be posted online. The papers have been peer reviewed and then revised as necessary by the authors but have not been copyedited, formatted, or assigned to an issue.The date on which each paper is posted is considered the publication date. The papers are fully citable by doi.The following statement appears on papers posted in First Look:MPMI "First Look" paper • doi: 10.1094/MPMI-00-00-0000 • posted 00/00/201XThis paper has been peer reviewed and accepted for publication but has not yetbeen copyedited or proofread. The final published version may differ.

Molecular Psychiatry publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatment. The emphasis is on studies at the interface of pre-clinical and clinical research, including studies at the cellular, molecular, integrative, clinical, imaging and psychopharmacology levels.